Table 8.

Summary of available evidence of surgical outcomes during COVID-19 pandemic

Author	Period (2020)	Total	COVID-19 (+)	COVID-19 mortality	Respiratory morbidity	Major complications*
COVIDSurg collaborative	January-March	1128	1128	23.8% (n = 268)	51.2% (n = 577)	–
Doglietto et al	February-April	333	41	19.5% (n = 8)	58.5% (n = 24)	41.5% (n = 17)
Seretis et al	March–May	100	3	0%	66.6% (n = 2)	–
Lei et al	January–February	34	34	20.5% (n = 7)	44.1% (n = 15)	–
Di Martino et al	February–March	213	15	20% (n = 3)	33% (n = 5)	26.6% (n = 4)
Aminian et al	February	4	4	50% (n = 2)	100% (n = 4)	–
Shrikhande et al	March–April	494	6	0%	–	–
Seeliger et al	March–May	127	13	23% (n = 3)	61.5% (n = 8)	53.8% (n = 7)
Carpio Colmenares et al	March–June	59	1	0%	–	5.1% (n = 3)
González-Catalayud et al	April–July	42	36	42.8% (n = 18)	–	–

*Clavien-Dindo ≥ III